iShares NASDAQ US Biotechnology UCITS ETF (LON:BTEC)
London · Delayed Price · Currency is GBP · Price in USD 6.48
-0.11 (-1.71%)
Aug 6, 2025, 4:35 PM BST
LON:BTEC Holdings Information
LON:BTEC is an equity ETF with a total of 265 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 7.67%, Amgen at 7.56%, Gilead Sciences at 7.55%, Regeneron Pharmaceuticals at 6.24%, and Alnylam Pharmaceuticals at 4.84%.
Total Holdings
265
Top 10 Percentage
47.04%
Asset Class
Equity
ETF Category
Health Care
Assets
531.34M
PE Ratio
25.98
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 7.67% |
| 2 | AMGN | Amgen Inc. | 7.56% |
| 3 | GILD | Gilead Sciences, Inc. | 7.55% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.24% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.84% |
| 6 | AZN | AstraZeneca PLC | 4.63% |
| 7 | ARGX | argenx SE | 2.26% |
| 8 | SMMT | Summit Therapeutics Inc. | 2.13% |
| 9 | INSM | Insmed Incorporated | 2.10% |
| 10 | BIIB | Biogen Inc. | 2.05% |
| 11 | RPRX | Royalty Pharma plc | 1.66% |
| 12 | ILMN | Illumina, Inc. | 1.59% |
| 13 | INCY | Incyte Corporation | 1.55% |
| 14 | UTHR | United Therapeutics Corporation | 1.41% |
| 15 | SNY | Sanofi | 1.39% |
| 16 | NBIX | Neurocrine Biosciences, Inc. | 1.35% |
| 17 | ONC | BeOne Medicines Ltd. | 1.32% |
| 18 | MEDP | Medpace Holdings, Inc. | 1.29% |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 1.18% |
| 20 | BNTX | BioNTech SE | 1.14% |
| 21 | MRNA | Moderna, Inc. | 1.13% |
| 22 | ASND | Ascendis Pharma A/S | 1.12% |
| 23 | VTRS | Viatris Inc. | 1.10% |
| 24 | EXEL | Exelixis, Inc. | 1.08% |
| 25 | TEM | Tempus AI, Inc. | 0.98% |
As of Aug 1, 2025